K
Kaixiong Tao
Researcher at Huazhong University of Science and Technology
Publications - 234
Citations - 5627
Kaixiong Tao is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 31, co-authored 189 publications receiving 3721 citations.
Papers
More filters
Journal ArticleDOI
Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial
Yanfeng Hu,Chang-Ming Huang,Yihong Sun,Xiangqian Su,Hui Cao,Jiankun Hu,Yingwei Xue,Jian Suo,Kaixiong Tao,Xianli He,Hongbo Wei,Mingang Ying,Weiguo Hu,Xiaohui Du,Pingyan Chen,Hao Liu,Chao-Hui Zheng,Fenglin Liu,Jiang Yu,Ziyu Li,Gang Zhao,Xinzu Chen,Kuan Wang,Ping Li,Jiadi Xing,Guoxin Li +25 more
TL;DR: Experienced surgeons can safely perform LG with D2 lymphadenectomy for AGC, and the morbidity and mortality within 30 days after surgery between the LG and OG groups were compared on the basis of the modified intention-to-treat principle.
Journal ArticleDOI
Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial
Jiang Yu,Chang-Ming Huang,Yihong Sun,Xiangqian Su,Hui Cao,Jiankun Hu,Kuan Wang,Jian Suo,Kaixiong Tao,Xianli He,Hongbo Wei,Mingang Ying,Weiguo Hu,Xiaohui Du,Yanfeng Hu,Hao Liu,Chao-Hui Zheng,Ping Li,Jian-Wei Xie,Fenglin Liu,Ziyu Li,Gang Zhao,Kun Yang,Chunxiao Liu,Hao-jie Li,Pingyan Chen,Jiafu Ji,Guoxin Li +27 more
TL;DR: Among patients with a preoperative clinical stage indicating locally advanced gastric cancer, laparoscopic distal Gastrectomy compared with open distal gastrectomy, did not result in inferior disease-free survival at 3 years.
Journal ArticleDOI
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Hang Li,Ke Wu,Kaixiong Tao,Li-Bo Chen,Qichang Zheng,Xiaoming Lu,Jun Liu,Liang Shi,Chuanqiao Liu,Guobin Wang,Weiping Zou +10 more
TL;DR: It is shown that the numbers of Tim‐3+ tumor‐infiltrating cells were negatively associated with patient survival and the data suggest that this pathway could be an immunotherapeutic target in patients with HBV‐associated HCC.
Journal ArticleDOI
Characteristics of Household Transmission of COVID-19.
Wei Li,Bo Zhang,Jianhua Lu,Shihua Liu,Zhiqiang Chang,Cao Peng,Xinghua Liu,Peng Zhang,Yan Ling,Kaixiong Tao,Jianying Chen +10 more
TL;DR: The secondary attack rate of Sars-CoV-2 in household is 16.3%.
Journal ArticleDOI
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li,Takashi Tanikawa,Ilona Kryczek,Houjun Xia,Gaopeng Li,Ke Wu,Shuang Wei,Lili Zhao,Linda Vatan,Bo Wen,Pan Shu,Duxin Sun,Celina G. Kleer,Max S. Wicha,Michael S. Sabel,Kaixiong Tao,Guobin Wang,Weiping Zou +17 more
TL;DR: T tumor glycolysis orchestrates a molecular network of the AMPK-ULK1, autophagy, and CEBPB pathways to affect MDSCs and maintain tumor immunosuppression and is associated with poor human TNBC outcome.